Evidence map›Paper›PMID 28943569›Full record

ArticleInternal medicine (Tokyo, Japan)2017

Intrahepatic Cholangiolocellular and Cholangiocellular Carcinoma - Differences in the

Yoshiko Takahashi, Shuichi Sato, Hitomi Ishitobi, Makoto Nagaoka, Yoshiya Kobayashi, Hiroyuki Fukuhara, Mika Yuki, Yoshinori Komazawa, Hiroyuki Kuroda, Toshihiro Shizuku

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yoshiko TakahashiDepartment of Internal Medicine, Izumo City General Medical Center, Japan.
Shuichi SatoDepartment of Gastroenterology and Hepatology, Shimane University Faculty of Medicine, Japan.
Hitomi IshitobiDepartment of Internal Medicine, Izumo City General Medical Center, Japan.
Makoto NagaokaDepartment of Internal Medicine, Izumo City General Medical Center, Japan.
Yoshiya KobayashiDepartment of Internal Medicine, Izumo City General Medical Center, Japan.
Hiroyuki FukuharaDepartment of Internal Medicine, Izumo City General Medical Center, Japan.
Mika YukiDepartment of Internal Medicine, Izumo City General Medical Center, Japan.
Yoshinori KomazawaDepartment of Internal Medicine, Izumo City General Medical Center, Japan.
Hiroyuki KurodaDepartment of Radiology, Izumo City General Medical Center, Japan.
Toshihiro ShizukuDepartment of Internal Medicine, Izumo City General Medical Center, Japan.
Shimane University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cholangiolocellular carcinoma is a minor primary cancerous tumor of the liver and its coexistence with intrahepatic cholangiocarcinoma in the liver is rare. We herein report a case of concurrent cholangiolocellular carcinoma and intrahepatic cholangiocarcinoma in the liver, in addition to a rectal G1 neuroendocrine tumor, a so-called carcinoid. The intrahepatic tumors showed a different uptake in the

Indexed as

Aged, 80 and overBile Duct NeoplasmsBile Ducts, IntrahepaticCholangiocarcinomaFluorodeoxyglucose F18HumansLiver NeoplasmsMalePositron Emission Tomography Computed TomographyRectal NeoplasmsTomography, Spiral ComputedFluorodeoxyglucose F1818F-fluoro-2-deoxyglucose positron emission tomography/computed tomographycholangiocellular carcinomacholangiolocellular carcinomacombined hepatocellular cholangiocarcinomaneuroendocrine tumorwith stem cell features

Identifiers

PMID28943569
PMCPMC5725856
OpenAlexW2758117897

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.